Stockreport

Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market [Yahoo! Finance]

Integra LifeSciences Holdings Corporation  (IART) 
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.integralife.com
PDF drug-eluting biomatrix technologies, today announced the appointment of Pete Ligotti as Chief Commercial Officer. Mr. Ligotti will lead the commercialization for NXT-41x [Read more]